Moving towards a more environmentally sustainable pharmaceutical industry: recommendations for industry and the transition to green HTA

Click to increase image sizeClick to decrease image size

Declaration of interest

I Firth was previously employed by the Office of Health Economics, a registered charity and Independent Research Organization, which receives funding from a variety of sources, including the Association of the British Pharmaceutical Industry (ABPI). J Hitch, N Henderson and G Cookson are currently employed by the Office of Health Economics, a registered charity and Independent Research Organization, which receives funding from a variety of sources, including the Association of the British Pharmaceutical Industry (ABPI). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

One peer reviewer declares that they are a Visiting Senior Fellow at the Office of Health Economics. Peer reviewers on this manuscript have no other relevant financial relationships or otherwise to disclose.

Additional information

Funding

This paper has not been sponsored or funded. The larger project on which this article is based was funded by the Association of the British Pharmaceutical Industry (ABPI).